Combining Prostate Health Index and MRI to Improve Detection of High-Grade Prostate Cancer in Minorities
Using Prostate Health Index and MRI in Combination for Cost-effectively Detecting High-Grade Prostate Cancer in Minorities
This study is looking at how well two tests, the Prostate Health Index and multi-parametric MRI, can help find serious prostate cancer in minority groups, aiming to make sure that fewer men have to go through unnecessary biopsies while still catching any important cases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10916260 on NIH RePORTER |
What this research studies
This research investigates the use of the Prostate Health Index (PHI) and multi-parametric MRI (MP-MRI) to enhance the detection of high-grade prostate cancer, particularly in minority populations. The study aims to identify effective thresholds for these tests to reduce unnecessary prostate biopsies while ensuring that clinically significant cancers are not missed. By focusing on cost-effectiveness and validation in underrepresented groups, the research seeks to improve diagnostic accuracy and patient outcomes. Patients may be involved in observational studies to assess the effectiveness of these combined diagnostic approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research include minority men at risk for prostate cancer, particularly those who may benefit from improved diagnostic methods.
Not a fit: Patients who do not belong to minority groups or those who are not at risk for prostate cancer may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and cost-effective detection of high-grade prostate cancer, reducing unnecessary procedures for patients.
How similar studies have performed: Previous studies have shown promise in using similar diagnostic approaches, but this research specifically addresses gaps in validation for minority populations.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Murphy, Adam Bryant — Northwestern University at Chicago
- Study coordinator: Murphy, Adam Bryant
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.